Trial Details
COMPLETEDBasic Information
| Clinical ID | c1573 |
|---|---|
| Identifier | NCT04857112 |
| Trial Title | Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Low Dose MT-1303|DRUG: High Dose MT-1303|DRUG: Placebo|DRUG: MT-1303 |
Participant Information
| Sponsor | Bausch Health Americas, Inc. |
|---|---|
| City | Chandler |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2021-09-29 |
|---|---|
| Primary Completion Date | 2024-09-03 |
| Completion Date | 2024-11-08 |